Open access
Aug 2026
Inhibition of amyloid β aggregation by venetoclax: a computational and in vitro experimental approach
Findings support the potential of venetoclax as a repurposed therapeutic candidate for AD in the inhibition of Aβ aggregation and mitigated Aβ-induced neurotoxicity by stabilizing Aβ peptide dynamics.
Bei-Bei Liu, Hecheng Wang, Yi-Le He et al.
· RSC Advances · 0 citations